Senior Director, Precision Medicine Initiatives
LUNGevity Foundation
Nikki Martin is Senior Director of Precision Medicine Initiatives at LUNGevity Foundation where she focuses on accelerating access to precision medicine, especially biomarker testing, for lung cancer patients. Nikki is passionate about the critical need for biomarker testing in lung cancer to ensure that the newly diagnosed and those at disease progression and recurrence have the most information possible about their unique type of lung cancer in order to access the appropriate therapies or clinical trials.
Prior to joining LUNGevity, Nikki worked in Alliance & Advocacy Relations at Genentech where she championed awareness of unmet needs and driving change in the patient community. She led advocacy outreach around Next Generation Sequencing and CMS' 14-day rule and expanding collaboration between CME providers and advocacy groups on provider and patient education on shared decision making.
Previous to Genentech, Nikki held two roles at Grifols/Novartis Diagnostics, first as Associate Director, Global Communications and later as Associate Director, Global Public Affairs. In those roles, she worked with global partners including sickle cell disease, hemophilia, and thalassemia patient advocacy groups, the Pan American Health Organization (PAHO), and the Asia Pacific Economic Cooperation (APEC) to educate the public, policy makers and other stakeholders on improving transfusion safety. She started her career in Japan where she worked at Cosmo PR advising healthcare clients on public relations activities in the Japanese market.
She earned her MA in Commercial Diplomacy from the Monterey Institute of International Studies (now the Middlebury Institute of International Studies), and a BS in Anthropology and BA in Spanish from Santa Clara University. She is an avid open water swimmer and runs Adult Learn to Swim Programs in her community. Nikki lives in Davis, CA with her wife and two dogs, Mia and Stuart.
